Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ARTLARTELO BIOSCIENCES, INC.

Nasdaq · CIK 0001621221
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts287

Identity from submissions API

NameARTELO BIOSCIENCES, INC.
CIK0001621221
TickersARTL
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN331220924
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone858-925-7049
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • REACTIVE MEDICAL INC. (2017-02-10T05:00:00.000Z → 2017-04-17T04:00:00.000Z)
  • KNIGHT KNOX DEVELOPMENT CORP. (2014-10-08T04:00:00.000Z → 2017-02-06T05:00:00.000Z)
Business address
505 LOMAS SANTA FE, SUITE 160
SOLANA BEACH
CA
92075
CA
Mailing address
505 LOMAS SANTA FE, SUITE 160
SOLANA BEACH
CA
92075
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

466 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q FORM 10-Q 0001640334-26-001776 001-38951 261543427 34 4777308 1 1
2026-10-09 8-K FORM 8-K 8.01 0001640334-26-001665 001-38951 261453695 34 143795 1 1
2026-08-27 8-K FORM 8-K 3.03,5.03,7.01,9.01 0001640334-26-001421 001-38951 261325289 34 721652 1 1
2026-08-20 10-Q/A FORM 10-Q/A 0001640334-26-001400 001-38951 261300323 34 234696 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003551 005-90653 261277006 34 10728
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-088826 005-90653 261270831 34 10519
2026-08-12 10-Q FORM 10-Q 0001640334-26-001323 001-38951 261268053 34 6183178 1 1
2026-07-21 4 FORM 4 0001640334-26-001231 13928
2026-07-21 4 FORM 4 0001640334-26-001229 13737
2026-07-21 4 FORM 4 0001640334-26-001227 13807
2026-07-21 4 FORM 4 0001640334-26-001225 13807
2026-07-21 4 FORM 4 0001640334-26-001223 13834
2026-07-21 4 FORM 4 0001640334-26-001221 13912
2026-07-17 8-K FORM 8-K 5.07 0001640334-26-001198 001-38951 261184136 34 150254 1 1
2026-07-16 DEFA14A DEFA14A 0001640334-26-001189 001-38951 261179554 34 27844
2026-07-16 DEFA14A DEFA14A 0001640334-26-001186 001-38951 261178312 34 218090
2026-07-02 DEFA14A DEFA14A 0001640334-26-001147 001-38951 261150961 34 475077
2026-06-22 PRER14A PRER 14A 0001640334-26-001106 001-38951 261107026 34 73667
2026-06-05 ARS ARS 0001640334-26-001011 001-38951 261069099 34 12145134
2026-06-05 DEFA14A DEFA14A 0001640334-26-001009 001-38951 261069070 34 364661
2026-06-05 DEF 14A DEF 14A 0001640334-26-001007 001-38951 261069024 34 2901061 1 1
2026-05-27 8-K FORM 8-K 1.01,8.01,9.01 0001640334-26-000973 001-38951 261026923 34 441116 1 1
2026-05-26 PRE 14A FORM PRE 14A 0001640334-26-000969 001-38951 261020954 34 2917402 1 1
2026-05-26 424B5 424B5 0001640334-26-000966 333-295537 261020696 33 424666
2026-05-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001705 333-295537 261001268 33 1942
2026-05-18 424B5 FORM 424B5 0001640334-26-000926 333-273153 26994051 33 16657
2026-05-15 CORRESP filename1.htm 0001640334-26-000905 6277
2026-05-15 8-K FORM 8-K 1.02 0001640334-26-000903 001-38951 26986591 34 141203 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002123 005-90653 26984001 34 10583
2026-05-14 10-Q FORM 10-Q 0001640334-26-000869 001-38951 26978806 34 8675712 1 1
2026-05-14 S-3/A FORM S-3/A 0001640334-26-000867 333-295537 26978507 33 367764
2026-05-11 UPLOAD filename1.pdf 0000000000-26-004788 333-295537 147645
2026-05-04 S-3 FORM S-3 0001640334-26-000820 333-295537 26938552 33 526494 1 1
2026-04-16 424B3 424B3 0001640334-26-000761 333-294912 26865706 33 240984
2026-04-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001202 333-294912 26865543 33 1941
2026-04-13 CORRESP filename1.htm 0001640334-26-000693 4593
2026-04-13 UPLOAD filename1.pdf 0000000000-26-003674 333-294912 40264
2026-04-07 S-1 FORM S-1 0001640334-26-000670 333-294912 26845170 33 648664 1 1
2026-04-07 8-K FORM 8-K 8.01,9.01 0001640334-26-000662 001-38951 26842951 34 164434 1 1
2026-04-06 D xslFormDX01/primary_doc.xml 06b 0001621221-26-000005 021-579170 26840290 33 13531
2026-04-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-039993 005-90653 26838704 34 15732
2026-03-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001002 333-294579 26816643 33 1941
2026-03-30 8-K FORM 8-K 1.01,3.02,7.01,8.01,9.01 0001640334-26-000574 001-38951 26813640 34 974060 1 1
2026-03-27 D xslFormDX01/primary_doc.xml 06b 0001621221-26-000004 021-578154 26808351 33 12245
2026-03-27 D xslFormDX01/primary_doc.xml 06b 0001621221-26-000003 021-578152 26808328 33 12245
2026-03-27 D xslFormDX01/primary_doc.xml 06b 0001621221-26-000002 021-578151 26808315 33 12299
2026-03-27 RW FORM RW 0001640334-26-000558 333-294506 26801120 NE 9460
2026-03-26 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001640334-26-000554 001-38951 26799130 34 531847 1 1
2026-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000932 333-294506 26794179 33 1941
2026-03-25 CORRESP filename1.htm 0001640334-26-000547 6278
2026-03-24 S-1 FORM S-1 0001640334-26-000543 333-294579 26787689 33 683373 1 1
2026-03-24 S-1/A FORM-S-1/A 0001640334-26-000540 333-294506 26787381 33 615270
2026-03-23 S-1/A FORM-S-1/A 0001640334-26-000515 333-294506 26783368 33 437390
2026-03-20 CORRESP filename1.htm 0001640334-26-000508 5395
2026-03-20 CORRESP filename1.htm 0001640334-26-000506 8401
2026-03-20 S-1 FROM-S-1 0001640334-26-000502 333-294506 26779190 33 1111292 1 1
2026-03-18 8-K FORM 8-K 1.01,3.02,9.01 0001640334-26-000475 001-38951 26770191 34 508688 1 1
2026-03-17 8-K FORM 8-K 2.02,8.01,9.01 0001640334-26-000461 001-38951 26762867 34 3956483 1 1
2026-03-13 UPLOAD filename1.pdf 0000000000-26-002625 377-09128 40573
2026-03-09 DRS filename1.htm 0001640334-26-000403 377-09128 26736253 33 519352
2026-03-06 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001640334-26-000395 001-38951 26728549 34 531952 1 1
2026-02-24 10-K FORM 10-K 0001640334-26-000368 001-38951 26667597 34 5231301 1 1
2026-02-06 D xslFormDX01/primary_doc.xml 06b 0001621221-26-000001 021-572642 26604291 33 12395
2026-02-05 8-K FORM 8-K 1.01,3.02,9.01 0001640334-26-000227 001-38951 26602794 34 671036 1 1
2026-02-05 8-K FORM 8-K 8.01 0001640334-26-000221 001-38951 26600599 34 145330 1 1
2026-02-02 4 FORM 4 0001640334-26-000199 5923
2026-02-02 4 FORM 4 0001640334-26-000198 5980
2026-02-02 4 FORM 4 0001640334-26-000197 5959
2026-02-02 4 FORM 4 0001640334-26-000196 5984
2026-02-02 4 FORM 4 0001640334-26-000195 6062
2026-02-02 4 FORM 4 0001640334-26-000194 5945
2026-02-02 4 FORM 4 0001640334-26-000193 6037
2026-02-02 4 FORM 4 0001640334-26-000192 6040
2026-01-30 8-K FORM 8-K 5.07 0001640334-26-000181 001-38951 26583482 34 148727 1 1
2026-01-16 8-K FORM 8-K 3.01 0001640334-26-000109 001-38951 26540387 34 143128 1 1
2026-01-07 DEFA14A DEFA 14A 0001640334-26-000049 001-38951 26515754 34 510842
2026-01-02 8-K FORM 8-K 7.01 0001640334-26-000005 001-38951 26502596 34 143155 1 1
2025-12-11 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001640334-25-002309 001-38951 251565139 34 969016
2025-12-11 DEF 14A DEF 14A 0001640334-25-002308 001-38951 251564998 34 1559891 1 1
2025-12-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003484 333-291597 251544872 33 1942
2025-12-01 CORRESP filename1.htm 0001640334-25-002233 8251
2025-11-25 8-K FORM 8-K 3.01 0001640334-25-002210 001-38951 251521051 34 142960 1 1
2025-11-17 3 PRIMARY DOCUMENT 0001640334-25-002155 6267
2025-11-17 S-1 FORM S-1 0001640334-25-002154 333-291597 251491690 33 985974 1 1
2025-11-14 8-K FORM 8-K 5.03,9.01 0001640334-25-002118 001-38951 251485996 34 151047 1 1
2025-11-12 10-Q FORM 10-Q 0001640334-25-002022 001-38951 251469052 34 4120787 1 1
2025-11-10 D xslFormDX01/primary_doc.xml 06b 0001640334-25-001998 021-563578 251465904 33 11961
2025-10-31 8-K FORM 8-K 1.01,2.03,3.02,9.01 0001640334-25-001930 001-38951 251437971 34 406879 1 1
2025-10-30 4 FORM 4 0001640334-25-001925 13320
2025-10-30 4 FORM 4 0001640334-25-001923 13451
2025-10-30 4 FORM 4 0001640334-25-001921 13388
2025-10-27 8-K FORM 8-K 5.02,9.01 0001640334-25-001880 001-38951 251417518 34 404474 1 1
2025-10-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000921895-25-002780 005-90653 251408175 34 11718
2025-10-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000921895-25-002763 005-90653 251401448 34 258220
2025-10-17 8-K FORM 8-K 1.01,9.01 0001640334-25-001856 001-38951 251401183 34 247449 1 1
2025-10-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000921895-25-002691 005-90653 251375014 34 8561
2025-10-01 8-K FORM 8-K 1.01,7.01,9.01 0001640334-25-001766 001-38951 251365691 34 679584 1 1
2025-10-01 424B5 424B5 0001640334-25-001763 333-273153 251363143 33 539461
2025-09-30 424B5 424B5 0001640334-25-001749 333-273153 251358161 33 562905
2025-09-30 424B5 424B5 0001640334-25-001747 333-273153 251358157 33 18243
2025-09-29 DRS filename1.htm 0001640334-25-001740 377-08523 251356305 33 562011
2025-09-19 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0000921895-25-002596 005-90653 251325605 34 64448
2025-09-15 8-K FORM 8-K 8.01,9.01 0001640334-25-001680 001-38951 251314499 34 144829 1 1
2025-09-10 8-K FORM 8-K 5.03,9.01 0001640334-25-001660 001-38951 251304700 34 160275 1 1
2025-09-05 8-K FORM 8-K 1.01,7.01,9.01 0001640334-25-001642 001-38951 251297496 34 674799 1 1
2025-09-05 424B5 424B5 0001640334-25-001629 333-273153 251295602 33 557748
2025-09-04 424B5 424B5 0001640334-25-001624 333-273153 251291904 33 560218
2025-09-04 424B5 424B5 0001640334-25-001622 333-273153 251291888 33 18499
2025-09-03 8-K FORM 8-K 8.01 0001640334-25-001617 001-38951 251291196 34 145630 1 1
2025-08-29 8-K FORM 8-K 5.07 0001640334-25-001613 001-38951 251281576 34 151765 1 1
2025-08-20 8-K FORM 8-K 1.02,9.01 0001640334-25-001570 001-38951 251237203 34 222279 1 1
2025-08-13 D xslFormDX01/primary_doc.xml 06b 0001786236-25-000029 021-554520 251209247 33 11544
2025-08-13 10-Q FORM 10-Q 0001640334-25-001429 001-38951 251209044 34 4066170 1 1
2025-08-07 DEF 14A DEF 14A 0001640334-25-001376 001-38951 251194070 34 1865666
2025-08-07 8-K FORM 8-K 1.01,3.02,9.01 0001640334-25-001375 001-38951 251193789 34 306480 1 1
2025-08-04 8-K FORM 8-K 1.01,3.02,7.01,8.01,9.01 0001640334-25-001334 001-38951 251178027 34 833448 1 1
2025-07-28 PRE 14A PRE 14A 0001640334-25-001329 001-38951 251155585 34 1848113
2025-07-18 8-K FORM 8-K 1.01,9.01 0001640334-25-001240 001-38951 251134906 34 456867 1 1
2025-07-18 424B5 424B5 0001640334-25-001239 333-273153 251134904 33 305851
2025-07-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002274 333-288653 251132549 33 1942
2025-07-16 CORRESP filename1.htm 0001640334-25-001219 7531
2025-07-16 UPLOAD filename1.pdf 0000000000-25-007505 333-288653 40279
2025-07-11 S-1 FORM S-1 0001640334-25-001190 333-288653 251119773 33 470309
2025-07-11 8-K FORM 8K 2.02,8.01,9.01 0001640334-25-001184 001-38951 251119383 34 4684771 1 1
2025-07-09 D xslFormDX01/primary_doc.xml 06b 0001640334-25-001156 021-551162 251113512 33 11112
2025-07-07 4 PRIMARY DOCUMENT 0001640334-25-001136 8448
2025-06-26 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001640334-25-001062 001-38951 251075087 34 691123 1 1
2025-06-13 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001640334-25-001046 001-38951 251047646 34 513993 1 1
2025-05-23 8-K FORM 8-K 3.01 0001640334-25-000935 001-38951 25982890 34 143304 1 1
2025-05-13 10-Q FORM 10-Q 0001640334-25-000825 001-38951 25937317 34 3312637 1 1
2025-05-05 4 FORM 4 0001640334-25-000789 7887
2025-05-05 4 FORM 4 0001640334-25-000788 7634
2025-05-05 4 FORM 4 0001640334-25-000787 7711
2025-05-01 8-K FORM 8-K 1.01,3.02,9.01 0001640334-25-000732 001-38951 25903518 34 371803 1 1
2025-04-29 8-K FORM 8-K 3.01 0001640334-25-000719 001-38951 25887677 34 151803 1 1
2025-03-20 S-8 FORM 8-K 0001640334-25-000439 333-285934 25754360 33 68734
2025-03-03 10-K FORM 10-K 0001640334-25-000335 001-38951 25693837 34 5016085 1 1
2024-12-23 4 FORM 4 0001640334-24-001935 5936
2024-12-23 4 FORM 4 0001640334-24-001933 5993
2024-12-23 4 FORM 4 0001640334-24-001931 5958
2024-12-23 4 FORM 4 0001640334-24-001929 5860
2024-12-23 4 FORM 4 0001640334-24-001927 5997
2024-12-23 4 FORM 4 0001640334-24-001925 6075
2024-12-20 8-K FORM 8-K 5.07 0001640334-24-001915 001-38951 241568564 34 156071 1 1
2024-11-12 10-Q FORM 10-Q 0001640334-24-001677 001-38951 241443555 34 3667610 1 1
2024-11-08 DEFA14A DEFA 14A 0001640334-24-001672 001-38951 241441157 34 733547
2024-11-08 DEF 14A DEF 14A 0001640334-24-001670 001-38951 241441125 34 509175
2024-11-08 ARS ARS 0001640334-24-001669 001-38951 241441080 34 1341188
2024-08-13 10-Q FORM 10-Q 0001640334-24-001221 001-38951 241198865 34 3722814 1 1
2024-06-17 25-NSE xslF25X02/primary_doc.xml 0001354457-24-000412 001-38951 241049405 34 3205
2024-05-13 10-Q FORM 10-Q 0001640334-24-000757 001-38951 24937146 34 3437680 1 1
2024-03-29 S-8 S-8 0001640334-24-000520 333-278359 24801591 33 77464
2024-03-25 10-K FORM 10-K 0001640334-24-000473 001-38951 24776921 34 4841442 1 1
2024-03-04 8-K FORM 8-K 5.02 0001640334-24-000345 001-38951 24715241 34 172989 1 1
2024-03-01 4 PRIMARY DOCUMENT 0001640334-24-000335 28403
2024-03-01 4 PRIMARY DOCUMENT 0001640334-24-000334 36586
2024-03-01 4 PRIMARY DOCUMENT 0001640334-24-000333 32177
2024-03-01 4 PRIMARY DOCUMENT 0001640334-24-000332 29100
2024-03-01 4 PRIMARY DOCUMENT 0001640334-24-000331 28033
2024-03-01 4 PRIMARY DOCUMENT 0001640334-24-000330 32173
2024-03-01 4 PRIMARY DOCUMENT 0001640334-24-000329 32093
2024-01-08 4 FORM 4 0001640334-24-000025 6226
2023-11-13 10-Q FORM 10-Q 0001640334-23-002073 001-38951 231395253 34 3831540 1 1
2023-08-10 10-Q FORM 10-Q 0001640334-23-001504 001-38951 231157245 34 3629858 1 1
2023-08-08 4 FORM 4 0001640334-23-001492 5871
2023-08-08 4 FORM 4 0001640334-23-001490 5928
2023-08-08 4 FORM 4 0001640334-23-001488 5893
2023-08-08 4 FORM 4 0001640334-23-001486 5795
2023-08-08 4 FORM 4 0001640334-23-001484 5936
2023-08-08 4 FORM 4 0001640334-23-001482 6009
2023-08-08 8-K FORM 8-K 5.02 0001640334-23-001479 001-38951 231151993 34 166297 1 1
2023-07-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-07-14 16:30:00 9999999995-23-002100 333-273153 231090387 33 1900
2023-07-12 CORRESP filename1.htm 0001640334-23-001262 12733
2023-07-10 UPLOAD filename1.pdf 0000000000-23-007304 40439
2023-07-07 DEL AM DEL AM 0001640334-23-001244 333-273153 231075249 33 7578
2023-07-06 S-3 FORM S-3 0001640334-23-001227 333-273153 231074007 33 364825
2023-07-03 8-K FORM 8-K 5.07 0001640334-23-001207 001-38951 231064737 34 192614 1 1
2023-07-03 4 FORM 4 0001640334-23-001205 5928
2023-07-03 4 FORM 4 0001640334-23-001204 5791
2023-07-03 4 FORM 4 0001640334-23-001203 5924
2023-07-03 4 FORM 4 0001640334-23-001202 5889
2023-07-03 4 FORM 4 0001640334-23-001201 6006
2023-07-03 4 FORM 4 0001640334-23-001200 5867
2023-05-16 DEFA14A DEFA 14A 0001640334-23-000921 001-38951 23928389 34 774878
2023-05-16 DEF 14A DEF 14A 0001640334-23-000919 001-38951 23928382 34 522067
2023-05-16 ARS ARS 0001140361-23-025051 001-38951 23928338 34 1061761
2023-05-11 10-Q FORM 10-Q 0001640334-23-000804 001-38951 23908935 34 5096297 1 1
2023-05-05 PRE 14A PRE 14A 0001640334-23-000777 001-38951 23894331 34 508960
2023-04-21 S-8 FORM S-8 0001640334-23-000696 333-271391 23836879 33 79652
2023-04-21 8-K FORM 8-K 5.03,9.01 0001640334-23-000694 001-38951 23836753 34 283153 1 1
2023-03-31 10-K FORM 10-K 0001640334-23-000509 001-38951 23783330 34 5542661 1 1
2023-03-13 8-K FORM 8-K 7.01 0001640334-23-000334 001-38951 23725618 34 146665 1 1
2023-02-01 4 FORM 4 0001640334-23-000144 6053
2022-11-08 10-Q FORM 10-Q 0001640334-22-002363 001-38951 221367309 34 3881812 1 1
2022-09-16 8-K FORM 8-K 5.03,5.07 0001640334-22-002036 001-38951 221248831 34 154160 1 1
2022-08-25 8-K FORM 8-K 8.01 0001640334-22-001896 001-38951 221193418 34 147911 1 1
2022-08-12 4 FORM 4 0001640334-22-001760 5245
2022-08-11 4 FORM 4 0001640334-22-001706 5245
2022-08-09 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001640334-22-001683 001-38951 221146495 34 497979 1 1
2022-08-09 10-Q FORM 10-Q 0001640334-22-001681 001-38951 221146462 34 3562168 1 1
2022-07-12 8-K FORM 8-K 5.07 0001640334-22-001477 001-38951 221079315 34 192449 1 1
2022-06-27 4 FORM 4 0001640334-22-001363 5782
2022-06-27 4 FORM 4 0001640334-22-001361 5706
2022-06-27 4 FORM 4 0001640334-22-001359 5843
2022-06-27 4 FORM 4 0001640334-22-001357 5829
2022-06-27 4 FORM 4 0001640334-22-001355 5804
2022-06-27 4 FORM 4 0001640334-22-001340 5839
2022-06-02 424B3 424B3 0001640334-22-001167 333-264967 22989078 33 494453
2022-05-31 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-05-31 16:30:00 9999999995-22-001644 333-264967 22985838 33 1899
2022-05-26 CORRESP filename1.htm 0001640334-22-001137 9797
2022-05-26 UPLOAD filename1.pdf 0000000000-22-005778 40352
2022-05-26 DEFA14A DEFA 14A 0001640334-22-001135 001-38951 22965752 34 670753
2022-05-26 DEF 14A DEF 14A 0001640334-22-001134 001-38951 22965746 34 731588
2022-05-20 D xslFormDX01/primary_doc.xml 06b 0001621221-22-000002 021-446459 22947131 33 11277
2022-05-16 S-1 FORM S-1 0001640334-22-001028 333-264967 22925740 33 2113480
2022-05-16 PRE 14A PRE 14A 0001640334-22-001026 001-38951 22925683 34 729282
2022-05-16 8-K FORM 8-K 1.01,3.02,9.01 0001640334-22-001024 001-38951 22925668 34 519337 1 1
2022-05-12 10-Q FORM 10-Q 0001640334-22-000949 001-38951 22915850 34 3239027 1 1
2022-04-07 S-8 FORM S-8 0001640334-22-000719 333-264183 22814067 33 69159
2022-03-21 10-KT FORM 10-KT 0001640334-22-000544 001-38951 22754283 34 5199517 1 1
2022-03-16 8-K FORM 8-K 8.01 0001640334-22-000506 001-38951 22743223 34 143911 1 1
2022-03-10 8-K FORM 8-K 5.02,5.03,8.01,9.01 0001640334-22-000444 001-38951 22726893 34 159981 1 1
2022-02-23 SC 13G/A c103099_sc13ga.htm 0000930413-22-000319 005-90653 22664409 34 54249
2022-02-09 SC 13G/A formsc13ga.htm 0001493152-22-003557 005-90653 22605037 34 217065
2022-02-04 SC 13G/A ARTL 13G/A 0001393825-22-000075 005-90653 22592835 34 54407
2022-01-12 10-Q FORM 10-Q 0001640334-22-000060 001-38951 22525601 34 2814233 1 1
2021-12-07 8-K FORM 8-K 5.02 0001640334-21-003064 001-38951 211476475 34 148815 1 1
2021-12-06 4 FORM 4 SUBMISSION 0000899243-21-047031 6161
2021-11-29 10-K FORM 10-K 0001640334-21-002983 001-38951 211452993 34 5347305 1 1
2021-09-17 8-K FORM 8-K 3.01,5.03 0001640334-21-002236 001-38951 211260748 34 152005 1 1
2021-07-26 4 FORM 4 0001640334-21-001686 5781
2021-07-26 4 FORM 4 0001640334-21-001685 5803
2021-07-26 4 FORM 4 0001640334-21-001683 5838
2021-07-26 4 FORM 4 0001640334-21-001681 5845
2021-07-26 4 FORM 4 0001640334-21-001679 5705
2021-07-26 4 FORM 4 0001640334-21-001677 5842
2021-07-26 4 FORM 4 0001640334-21-001675 5828
2021-07-26 8-K FORM 8-K 5.02 0001640334-21-001665 001-38951 211112533 34 16868
2021-07-20 8-K FORM 8-K 5.07 0001640334-21-001601 001-38951 211099160 34 35246
2021-07-15 8-K FORM 8-K 5.03,9.01 0001640334-21-001570 001-38951 211091518 34 21851
2021-07-12 10-Q FORM 10-Q 0001640334-21-001528 001-38951 211084531 34 3182728 1
2021-06-22 DEFA14A DEF A14A 0001640334-21-001399 001-38951 211036118 34 26283
2021-05-07 DEF 14A FORM DEF 14A 0001640334-21-001104 001-38951 21902987 34 271636
2021-04-20 4 FORM 4 0001640334-21-000982 5029
2021-04-13 10-Q FORM 10-Q 0001640334-21-000874 001-38951 21823156 34 3095736 1
2021-04-09 8-K FORM 8-K 1.01,1.02,9.01 0001640334-21-000821 001-38951 21818211 34 287838
2021-04-09 424B5 424B5 0001640334-21-000819 333-235917 21818175 33 433564
2021-03-09 8-K FORM 8-K 5.02 0001640334-21-000544 001-38951 21726378 34 49638
2021-03-09 4 FORM 4 0001640334-21-000542 6031
2021-03-09 4 FORM 4 0001640334-21-000540 6041
2021-03-09 3 FORM 3 0001640334-21-000538 8216
2021-03-01 SC 13G formsc13g.htm 0001493152-21-005110 005-90653 21698506 34 209450
2021-02-17 4 FORM 4 0001640334-21-000385 5864
2021-02-17 4 FORM 4 0001640334-21-000383 5921
2021-02-17 4 FORM 4 0001640334-21-000381 5944
2021-02-17 4 FORM 4 0001640334-21-000379 5928
2021-02-17 4 FORM 4 0001640334-21-000376 5788
2021-02-17 4 FORM 4 0001640334-21-000373 5925
2021-02-17 8-K FORM 8-K 5.02 0001640334-21-000370 001-38951 21645636 34 17837
2021-02-16 8-K FORM 8-K 8.01 0001640334-21-000356 001-38951 21641022 34 18429
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-023214 005-90653 21633645 34 53820
2021-02-10 SC 13G/A sc13ga110022artl_02102021.htm 0000921895-21-000288 005-90653 21613936 34 215770
2021-02-08 SC 13G ARTL 13G 0001393825-21-000010 005-90653 21602355 34 58937
2021-02-05 SC 13G/A ARTELO BIOSCIENCES, INC. 0000902664-21-000923 005-90653 21595734 34 115902
2021-01-21 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001640334-21-000115,2021-01-21 9999999995-21-000207 333-230658 21543641 33 1906
2021-01-21 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001640334-21-000171,2021-01-21 9999999995-21-000211 333-249083 21543642 33 1906
2021-01-21 POS AM POSAM 0001640334-21-000171 333-249083 21540263 33 112679
2021-01-15 POS AM POSAM 0001640334-21-000115 333-230658 21532876 33 106734
2021-01-15 POS AM POS AM 0001640334-21-000114 333-230658 21532850 33 108850
2021-01-15 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-21-002440 005-90653 21530936 34 41871
2021-01-14 10-Q FORM 10-Q 0001640334-21-000088 001-38951 21527554 34 2445670 1
2021-01-13 SC 13G ARTELO BIOSCIENCES, INC. 0000902664-21-000167 005-90653 21525150 34 78173
2020-12-16 S-8 FORM S-8 0001640334-20-003090 333-251387 201392575 33 499138
2020-12-07 4 FORM 4 0001640334-20-003022 5724
2020-12-07 3 FORM 3 0001640334-20-003020 8356
2020-12-04 8-K FORM 8-K 5.07 0001640334-20-003010 001-38951 201370518 34 23267
2020-12-02 8-K FORM 8-K 5.02 0001640334-20-002991 001-38951 201363816 34 19150
2020-11-20 8-K FORM 8-K 3.01 0001640334-20-002910 001-38951 201332574 34 17347
2020-11-09 DEF 14A DEF 14A 0001640334-20-002738 001-38951 201295951 34 939718
2020-11-04 10-K FORM 10-K 0001640334-20-002722 001-38951 201285218 34 4072270 1
2020-10-28 PRE 14A PRE 14A 0001640334-20-002672 001-38951 201268768 34 946363
2020-10-26 SC 13G SCHEDULE 13G 0001213900-20-033120 005-90653 201258965 34 72111
2020-10-22 SC 13G SCHEDULE 13G 0001213900-20-032762 005-90653 201253533 34 55329
2020-10-19 SC 13G sc13g10022artl_10192020.htm 0000921895-20-002643 005-90653 201246504 34 234844
2020-10-19 SC 13G c100618_sch13g.htm 0000930413-20-002453 005-90653 201246128 34 75364
2020-10-15 SC 13G ARTELO BIOSCIENCES, INC. 0000902664-20-003631 005-90653 201240711 34 88278
2020-10-15 SC 13G SCHEDULE 13G 0001104659-20-115170 005-90653 201240642 34 83977
2020-10-15 SC 13G ARTELO BIOSCIENCES, INC. 0000902664-20-003628 005-90653 201240371 34 115353
2020-10-14 8-K FORM 8-K 1.01,8.01,9.01 0001640334-20-002559 001-38951 201239221 34 474427
2020-10-13 424B4 424B4 - PROSPECTUS 0001640334-20-002532 333-249083 201234459 33 1393272
2020-10-09 S-1MEF S-1MEF 0001640334-20-002507 333-249398 201232027 33 94349
2020-10-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-10-08 17:30:00 9999999995-20-002794 333-249083 201232006 33 1898
2020-10-08 S-1/A FORM S-1/A 0001640334-20-002503 333-249083 201231070 33 125696
2020-10-07 CORRESP filename1.htm 0001640334-20-002496 5345
2020-10-07 CORRESP filename1.htm 0001640334-20-002495 9336
2020-10-07 S-1/A FORM S-1/A 0001640334-20-002484 333-249083 201227880 33 102922
2020-10-06 FWP FWP 0001640334-20-002473 333-249083 201225548 34 3072924
2020-10-06 S-1/A FORM S-1 AMENDMENT NO. 1 0001640334-20-002471 333-249083 201225547 33 6273518 1
2020-10-02 UPLOAD filename1.pdf 0000000000-20-009322 40341
2020-09-28 S-1 FORM S-1 0001640334-20-002415 333-249083 201201962 33 5831778 1
2020-07-14 8-K FORM 8-K 8.01,9.01 0001640334-20-001760 001-38951 201026455 34 43411
2020-07-14 424B5 425B5 0001640334-20-001759 333-235917 201026454 33 12832
2020-07-13 10-Q FORM 10-Q 0001640334-20-001749 001-38951 201025626 34 3106320 1
2020-06-26 8-K FORM 8-K 8.01 0001640334-20-001606 001-38951 20994361 34 13446
2020-06-25 S-8 FORM S-8 0001640334-20-001596 333-239434 20989820 33 134397
2020-06-22 8-K FORM 8-K 5.07 0001640334-20-001568 001-38951 20979704 34 32352
2020-05-19 4 FORM 4 0001640334-20-001281 7554
2020-05-18 D xslFormDX01/primary_doc.xml 06b 0001621221-20-000001 021-367219 20890582 33 10355
2020-05-08 DEF 14A DEF 14A 0001640334-20-001127 001-38951 20861029 34 1282817
2020-05-04 4 FORM 4 0001640334-20-001029 4643
2020-05-04 4 FORM 4 0001640334-20-001028 4723
2020-04-22 UPLOAD filename1.pdf 0000000000-20-003450 39798
2020-04-21 CORRESP filename1.htm 0001640334-20-000903 28797
2020-04-15 424B5 424B5 0001640334-20-000837 333-235917 20792474 33 23589
2020-04-15 8-K FORM 8-K 1.01,9.01 0001640334-20-000835 001-38951 20792453 34 239117
2020-04-14 424B5 424B5 0001640334-20-000811 333-235917 20789802 33 358174
2020-04-13 10-Q FORM 10-Q 0001640334-20-000802 001-38951 20789025 34 2794220 1
2020-04-10 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001640334-20-000737,2020-04-10 9999999995-20-000720 333-230658 20787721 33 1910
2020-04-07 UPLOAD filename1.pdf 0000000000-20-003006 49313
2020-04-07 POS AM POS AM 0001640334-20-000737 333-230658 20778289 33 7397893 1
2020-03-27 CORRESP filename1.htm 0001640334-20-000632 35300
2020-03-23 UPLOAD filename1.pdf 0000000000-20-002511 49093
2020-03-11 8-K FORM 8-K 5.02 0001640334-20-000473 001-38951 20705638 34 11767
2020-02-14 4 FORM 4 0001640334-20-000327 5589
2020-02-14 SC 13G SC 13G 0001640334-20-000317 005-90653 20620202 34 34758
2020-02-14 SC 13G SC 13G 0001640334-20-000316 005-90653 20620183 34 36903
2020-02-14 SC 13G FORM 13-G 0001640334-20-000315 005-90653 20620168 34 35383
2020-02-07 8-K FORM 8-K 8.01 0001640334-20-000210 001-38951 20584451 34 10689
2020-02-03 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-02-03 14:00:00 9999999995-20-000214 333-235917 20570551 33 1897
2020-02-03 CORRESP filename1.htm 0001640334-20-000182 9356
2020-01-21 UPLOAD filename1.pdf 0000000000-20-000515 46168
2020-01-15 S-3 FORM S-3 0001640334-20-000084 333-235917 20526964 33 348061
2020-01-15 S-8 FORM S-8 0001640334-20-000082 333-235916 20526960 33 995895
2020-01-14 10-Q FORM 10-Q 0001640334-20-000071 001-38951 20524974 34 2342724 1
2020-01-14 8-K FORM 8-K 2.02,9.01 0001640334-20-000073 001-38951 20524973 34 159644
2020-01-03 SC 13G/A SC 13G/A 0001104659-20-000711 005-90653 20504353 34 69599
2019-12-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-12-20 16:00:00 9999999995-19-002888 333-234372 191303344 33 1898
2019-12-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-12-20 16:00:00 9999999995-19-002879 333-232853 191303335 33 1898
2019-12-19 CORRESP filename1.htm 0001640334-19-002627 10024
2019-12-19 CORRESP filename1.htm 0001640334-19-002625 10045
2019-12-19 S-3/A FORM S-3 AMENDMENT NO. 2 0001640334-19-002622 333-232853 191294013 33 346490
2019-12-18 10-K/A FORM 10-K AMENDMENT NO. 1 0001640334-19-002608 001-38951 191291174 34 3237747 1
2019-12-13 4 FORM 4 0001640334-19-002583 8257
2019-12-13 3 FORM 3 0001640334-19-002582 7874
2019-12-06 8-K FORM 8-K 5.02 0001640334-19-002544 001-38951 191273253 34 17079
2019-11-25 S-3/A FORM S-3 AMENDMENT NO. 1 0001640334-19-002450 333-234372 191243832 33 349477
2019-11-25 S-3/A FORM S-3 AMENDMENT NO. 1 0001640334-19-002446 333-232853 191243806 33 384694
2019-11-25 10-K FORM 10-K 0001640334-19-002443 001-38951 191243720 34 3781969 1
2019-11-15 8-K FORM 8-K 7.01,9.01 0001640334-19-002370 001-38951 191225157 34 7074540
2019-11-12 CORRESP filename1.htm 0001640334-19-002235 4526
2019-11-08 CORRESP filename1.htm 0001640334-19-002217 9412
2019-11-08 UPLOAD filename1.pdf 0000000000-19-015344 46214
2019-11-05 4 FORM 4 0001640334-19-002181 5036
2019-11-01 4 FORM 4 0001640334-19-002169 8672
2019-10-30 S-3 FORM S-3 0001640334-19-002145 333-234372 191177201 33 386894
2019-10-17 4 FORM 4 0001640334-19-002067 5034
2019-10-11 4 FORM 4 0001640334-19-002035 5035
2019-09-06 8-K FROM 8-K 5.02 0001640334-19-001804 001-38951 191080040 34 17314
2019-08-30 4 FORM 4 0001640334-19-001786 5705
2019-08-30 4 FORM 4 0001640334-19-001783 5568
2019-08-30 4 FORM 4 0001640334-19-001781 5773
2019-08-30 4 FORM 4 0001640334-19-001779 5649
2019-08-30 4 FORM 4 0001640334-19-001777 5701
2019-08-30 4 FORM 4 0001640334-19-001775 5644
2019-07-31 UPLOAD filename1.pdf 0000000000-19-011880 46164
2019-07-26 S-3 FORM S-3 0001640334-19-001468 333-232853 19978203 33 353184
2019-07-15 8-K FORM 8-K 2.02,9.01 0001640334-19-001363 001-38951 19955436 34 41149
2019-07-15 10-Q FORM 10-Q 0001640334-19-001361 001-38951 19955245 34 2465259 1
2019-06-25 8-K FORM 8-K 1.01,5.03,8.01,9.01 0001640334-19-001230 001-38951 19918560 34 1146601
2019-06-25 424B4 PROSPECTUS 0001640334-19-001225 333-230658 19916716 33 3892806
2019-06-21 3 FORM 3 0001640334-19-001211 9354
2019-06-21 3 FORM 3 0001640334-19-001210 7697
2019-06-21 3 FORM 3 0001640334-19-001209 9927
2019-06-21 3 FORM 3 0001640334-19-001208 7793
2019-06-21 3 FORM 3 0001640334-19-001207 7682
2019-06-21 3 FORM 3 0001640334-19-001206 8830
2019-06-21 3 FORM 3 0001640334-19-001205 9912
2019-06-21 3 FORM 3 0001640334-19-001204 8046
2019-06-21 CERT 8A_Cert_ARTL.pdf 0001354457-19-000327 001-38951 19910872 34 80376
2019-06-21 8-A12B 8-A12B 0001640334-19-001191 001-38951 19909634 34 13314
2019-06-20 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-06-20 17:00:00 9999999995-19-001390 333-230658 19909748 33 1897
2019-06-20 CORRESP filename1.htm 0001640334-19-001183 7641
2019-06-20 CORRESP filename1.htm 0001640334-19-001182 8909
2019-06-20 S-1/A FORM S-1/A 0001640334-19-001174 333-230658 19907430 33 1495478
2019-06-10 S-1/A FORM S-1 AMENDMENT NO. 3 0001640334-19-001091 333-230658 19887503 33 7046059 1
2019-06-04 D xslFormDX01/primary_doc.xml 06b 0001640334-19-001043 021-341134 19877236 33 10278
2019-06-04 D xslFormDX01/primary_doc.xml 06b 0001640334-19-001041 021-341133 19877214 33 10393
2019-05-31 S-1/A FORM S-1 AMENDMENT NO. 2 0001640334-19-001007 333-230658 19871132 33 7046795 1
2019-05-29 S-1/A FORM S-1 AMENDMENT NO. 1 0001640334-19-001003 333-230658 19863397 33 7088187 1
2019-04-30 8-K FORM 8-K 1.01,3.02,8.01 0001640334-19-000730 333-199213 19782932 34 14344
2019-04-15 10-Q FORM 10-Q 0001640334-19-000608 333-199213 19748859 34 2150518 1
2019-04-01 S-1 FORM S-1 0001640334-19-000498 333-230658 19721133 33 3555610 1
2019-03-08 8-K FORM 8-K 8.01 0001640334-19-000362 333-199213 19667302 34 10986
2019-03-07 8-K FORM 8-K 5.02 0001640334-19-000358 333-199213 19663879 34 11909
2019-02-11 SC 13G/A SC 13G/A 0001144204-19-006177 005-90653 19584408 34 65626
2019-01-14 10-Q FORM 10-Q 0001640334-19-000036 333-199213 19525551 34 1116181 1
2018-11-29 10-K FORM 10-K 0001640334-18-002309 333-199213 181209237 34 2550787 1
2018-10-09 8-K FORM 8-K 8.01,9.01 0001640334-18-001881 333-199213 181112348 34 34140
2018-10-05 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2018-10-05 17:00:00 9999999995-18-002562 333-227571 181111756 33 1898
2018-10-04 UPLOAD filename1.pdf 0000000000-18-031298 46143

Latest XBRL company facts

One latest value per concept from companyfacts (287 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 937,177 2026-11-11 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
dei EntityPublicFloat Entity Public Float USD 9.29M 2025-06-30 2025 FY 10-K 2026-02-24 0001640334-26-000368
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 53,296 2025-01-01 2025-12-31 DEF 14A 2026-06-05 0001640334-26-001007
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 41,667 2025-01-01 2025-12-31 DEF 14A 2026-06-05 0001640334-26-001007
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 883,189 2025-01-01 2025-12-31 DEF 14A 2026-06-05 0001640334-26-001007
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.21M 2025-01-01 2025-12-31 DEF 14A 2026-06-05 0001640334-26-001007
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 7,070 2025-01-01 2025-12-31 DEF 14A 2026-06-05 0001640334-26-001007
ffd NetFeeAmt NetFeeAmt USD 788 2026-05-02 S-3 2026-05-04 0001640334-26-000820
ffd TtlFeeAmt TtlFeeAmt USD 788.05 2026-05-02 S-3 2026-05-04 0001640334-26-000820
ffd TtlOfferingAmt TtlOfferingAmt USD 75.00M 2026-05-02 S-3 2026-05-04 0001640334-26-000820
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-02 S-3 2026-05-04 0001640334-26-000820
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-02 S-3 2026-05-04 0001640334-26-000820
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 284,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 418,943 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 639,417 2019-08-31 2020 Q3 10-Q 2020-07-13 0001640334-20-001749
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 0 2026-06-30 2026 Q2 10-Q 2026-08-12 0001640334-26-001323
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1,584 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -242,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 76.64M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 55,616 2017-02-28 2017 Q2 10-Q 2017-04-14 0001640334-17-000697
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 145,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.02M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 15,151 2019-09-01 2019-11-30 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 1.50M 2020-09-01 2021-08-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 256,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001640334-26-000869
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 600 2016-09-01 2017-08-31 2018 FY 10-K 2018-11-29 0001640334-18-002309
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 83,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 169 2016-09-01 2017-02-28 2017 Q2 10-Q 2017-04-14 0001640334-17-000697
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 807,326 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap Assets Assets USD 6.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap AssetsCurrent Assets, Current USD 4.60M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 24,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001640334-23-000509
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 1.49M 2022-06-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 1.52M 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 1.99M 2022-06-30 2022 Q2 10-Q 2022-08-09 0001640334-22-001681
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 29,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001640334-22-001681
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4,198 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 7.42M 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-12 0001640334-22-000060
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 4.44M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 1.72M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001640334-25-002022
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD 8,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0001640334-23-000509
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.001 2026-03-31 2026 Q1 10-Q 2026-05-14 0001640334-26-000869
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 1 2019-06-25 2019 FY 10-K/A 2019-12-18 0001640334-19-002608
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 10.12M 2020-10-14 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 4.43B 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0.001 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 55.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CommonStockSharesHeldInEmployeeTrust Common Stock, Shares Held in Employee Trust USD 6.50M 2025-07-18 8-K 2026-03-17 0001640334-26-000461
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 937,177 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 937,177 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 600 2016-08-31 2017 FY 10-K 2017-11-29 0001640334-17-002551
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -7.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 208,000 2026-01-01 2026-03-31 2026 Q2 10-Q 2026-08-12 0001640334-26-001323
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 791,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001640334-25-001429
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap CryptoAssetFairValue CryptoAssetFairValue USD 325,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001640334-25-002022
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 55,000 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 91.8 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 665,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.12 2025-10-28 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 431 2017-05-31 2017 Q3 10-Q 2017-07-21 0001640334-17-001454
us-gaap DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net USD 720,000 2026-04-01 2026-04-02 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent Debt Securities, Available-for-sale, Amortized Cost, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001640334-23-000509
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001640334-24-001221
us-gaap DebtSecuritiesNoncurrent Debt Securities, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 424,000 2025-03-31 2025 Q1 10-Q 2025-05-13 0001640334-25-000825
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 291,670 2019-05-31 2019 Q3 10-Q 2019-07-15 0001640334-19-001361
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 424,000 2025-03-31 8-K 2025-07-11 0001640334-25-001184
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 1.80M 2020-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 7.82M 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap DepositAssets Deposit Assets USD 250,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001640334-25-002022
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 1,500 2020-02-29 2020 Q2 10-Q 2020-04-13 0001640334-20-000802
us-gaap Depreciation Depreciation USD 183 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 500 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DerivativeLiabilities Derivative Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 582,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001640334-26-000869
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 456,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 23,419 2015-02-28 2015 Q2 10-Q 2015-04-14 0001557240-15-000242
us-gaap DueFromRelatedParties Due from Related Parties USD 65,000 2018-01-26 2018 Q3 10-Q 2018-07-13 0001640334-18-001368
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 87,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0001640334-23-000804
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.79 2019-09-01 2020-02-29 2020 Q2 10-Q 2020-04-13 0001640334-20-000802
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.12 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -19.48 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.253 2017-09-01 2018-08-31 2019 FY 10-K/A 2019-12-18 0001640334-19-002608
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD -28,000 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 216,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001640334-26-001323
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 0.005 2013-09-01 2014-08-31 2015 Q2 10-Q 2015-04-14 0001557240-15-000242
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 522,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD -1.16M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 9.20M 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 2.04M 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 22,000 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -4.04M 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 1.21M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001640334-26-001323
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 519,532 2017-09-01 2018-08-31 2018 FY 10-K 2018-11-29 0001640334-18-002309
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -519,532 2017-09-01 2018-08-31 2018 FY 10-K 2018-11-29 0001640334-18-002309
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 1.35M 2024-01-01 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 29,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001640334-22-001681
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -2.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -221,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncreaseDecreaseInDeferredFuelCosts Increase (Decrease) in Deferred Fuel Costs USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001640334-26-000869
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 11,000 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-12 0001640334-22-000060
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 22,000 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-12 0001640334-22-000060
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 48,000 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap IncreaseDecreaseInMarketableSecuritiesRestricted Increase (Decrease) in Marketable Securities, Restricted USD -2,319 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 20,771 2019-09-01 2020-02-29 2020 Q2 10-Q 2020-04-13 0001640334-20-000802
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -13,340 2018-09-01 2019-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 65,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 169,264 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -5,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001640334-24-000757
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap InterestAndOtherIncome Interest and Other Income USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap InterestExpense Interest Expense USD 106,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap InterestExpenseOther Interest Expense, Other USD 106,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap InterestIncomeOther Interest Income, Other USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2017-09-01 2018-02-28 2018 Q2 10-Q/A 2018-05-14 0001640334-18-000943
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 6.41M 2024-12-31 2024 Q1 10-Q 2024-05-13 0001640334-24-000757
us-gaap Liabilities Liabilities USD 439,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 6.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap LiabilitiesCurrent Liabilities, Current USD 439,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap MarketableSecurities Marketable Securities USD 0 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2025-09-30 2025 Q3 10-Q 2025-11-12 0001640334-25-002022
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 248,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001640334-24-001677
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 0 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 2,140 2020-09-01 2021-02-28 2021 Q2 10-Q 2021-04-13 0001640334-21-000874
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 12.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 592,877 2017-09-01 2018-02-28 2018 Q2 10-Q/A 2018-05-14 0001640334-18-000943
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -887 2017-09-01 2018-02-28 2018 Q2 10-Q/A 2018-05-14 0001640334-18-000943
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -8.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -637,379 2017-09-01 2018-02-28 2018 Q2 10-Q/A 2018-05-14 0001640334-18-000943
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 130,000 2025-09-02 2025-09-04 2025 Q3 10-Q 2025-11-12 0001640334-25-002022
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -167,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap NotesPayableCurrent Notes Payable, Current USD 29,720 2017-05-31 2017 Q3 10-Q 2017-07-21 0001640334-17-001454
us-gaap OperatingExpenses Operating Expenses USD 6.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -6.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 87,000 2024-06-30 2024 Q2 10-Q 2024-08-13 0001640334-24-001221
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 40,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OperatingLeasePayments Operating Lease, Payments USD 15,000 2026-04-01 2026-04-14 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 37,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 37.78M 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap OtherAssets Other Assets USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0001640334-23-000804
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 30,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 30,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 51,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 49,000 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-13 0001640334-24-000757
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 49,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001640334-23-000804
us-gaap OtherNoncashExpense Other Noncash Expense USD 28,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 567 2020-09-01 2020-11-30 2021 Q1 10-Q 2021-01-14 0001640334-21-000088
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3,775 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap OtherReceivablesGrossCurrent Other Receivables, Gross, Current USD 29,558 2020-02-29 2020 Q2 10-Q 2020-04-13 0001640334-20-000802
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 16,484 2018-05-31 2018 Q3 10-Q 2018-07-13 0001640334-18-001368
us-gaap PaymentForAcquisitionCryptoAsset PaymentForAcquisitionCryptoAsset USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD -188,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001640334-26-000368
us-gaap PaymentsForRent Payments for Rent USD 45,000 2026-04-01 2026-04-14 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 75.00M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001640334-25-002022
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 582,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001640334-23-002073
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 1.52M 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 1.50M 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 688 2018-09-01 2019-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1,176 2019-09-01 2020-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap PaymentsToEmployees Payments to Employees USD 12,340 2017-09-01 2018-02-28 2018 Q2 10-Q/A 2018-05-14 0001640334-18-000943
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 23,148 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 159,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 903,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0001640334-23-000804
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 3,000 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 593,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 18,262 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001640334-23-000509
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 18.26M 2024-01-01 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 13.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 593,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001640334-26-001323
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 55,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001640334-24-000757
us-gaap ProceedsFromIssuanceOfUnsecuredDebt Proceeds from Issuance of Unsecured Debt USD 610,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.08M 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 75.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 5,000 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 29,400 2016-09-01 2017-08-31 2018 FY 10-K 2018-11-29 0001640334-18-002309
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001640334-23-000509
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -30,000 2016-09-01 2017-08-31 2018 FY 10-K 2018-11-29 0001640334-18-002309
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001640334-22-001681
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 1.51M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap ProceedsFromSaleOfFederalReserveStock Proceeds from Sale of Federal Reserve Bank Stock USD 75.00M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001640334-25-002022
us-gaap ProceedsFromSaleOfTradingSecuritiesHeldforinvestment Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment USD 2.69M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001640334-22-001681
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 237,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ProfessionalFees Professional Fees USD 26,000 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.43M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001640334-26-001323
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 63 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 230,000 2016-09-01 2017-05-31 2017 Q3 10-Q 2017-07-21 0001640334-17-001454
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 150,000 2017-05-31 2017 Q3 10-Q 2017-07-21 0001640334-17-001454
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap RepaymentsOfDebt Repayments of Debt USD 430,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001640334-26-000869
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 207,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -70.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 7,000 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 125,000 2018-01-01 2018-01-26 2018 Q2 10-Q/A 2018-05-14 0001640334-18-000943
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 20.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001640334-25-001429
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.30B 2019-06-01 2019-06-25 2021 FY 10-K 2021-11-29 0001640334-21-002983
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 1.51 2021-05-31 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 617,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.55 2019-09-01 2020-08-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.98 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.97 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-01-01 2025-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2024-01-01 2024-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2024-01-01 2024-12-31 8-K 2026-03-17 0001640334-26-000461
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 90,315 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 37.71 2021-12-31 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 24,838 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 25.69 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 74.00M 2019-09-01 2020-08-31 2022 FY 10-K 2023-03-31 0001640334-23-000509
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.63 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 24.15 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2020-08-31 2021 FY 10-K 2021-11-29 0001640334-21-002983
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 313,109 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.57 2020-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 878,017 2018-09-01 2019-08-31 2019 FY 10-K/A 2019-12-18 0001640334-19-002608
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 25.00M 2018-08-01 2018-08-17 2022 FY 10-K 2023-03-31 0001640334-23-000509
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4.89 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 3.92 2020-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 151,505 2020-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap SharePrice Share Price USD/shares 0.95 2019-04-12 2019 Q2 10-Q 2019-04-15 0001640334-19-000608
us-gaap SharesIssued Shares, Issued shares 575,000 2017-05-31 2017 Q3 10-Q 2017-07-21 0001640334-17-001454
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.65 2018-01-26 2018 Q3 10-Q 2018-07-13 0001640334-18-001368
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 6.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap StockIssued1 Stock Issued USD 38,741 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001640334-24-000473
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 2,264 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 15,348 2024-01-01 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 153,351 2025-06-01 2025-06-26 8-K 2026-03-17 0001640334-26-000461
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 70,897 2024-01-01 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 520,000 2017-09-01 2018-08-31 2018 FY 10-K 2018-11-29 0001640334-18-002309
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 10 2018-09-01 2019-08-31 2019 FY 10-K/A 2019-12-18 0001640334-19-002608
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001640334-22-001681
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 539,000 2019-09-01 2020-08-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 208,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 100,000 2019-09-01 2020-08-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 208,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 30,000 2013-09-01 2014-08-31 2015 Q2 10-Q 2015-04-14 0001557240-15-000242
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 112,000 2024-01-01 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.86M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 679,000 2024-01-01 2024-12-31 8-K 2025-07-11 0001640334-25-001184
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 17.46 2025-06-01 2025-06-26 8-K 2026-03-17 0001640334-26-000461
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 100,000 2018-09-01 2019-08-31 2020 FY 10-K 2020-11-04 0001640334-20-002722
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD -2,500 2019-12-01 2020-02-29 2021 Q3 10-Q 2021-07-12 0001640334-21-001528
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD -400 2016-09-01 2017-08-31 2018 FY 10-K 2018-11-29 0001640334-18-002309
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 2.36M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001640334-22-002363
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -5,000 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 168.48 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 5.64M 2019-02-28 2019 Q2 10-Q 2019-04-15 0001640334-19-000608
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 367,161 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001640334-26-001776
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 33.45B 2021-09-01 2021-12-31 2022 Q1 10-KT 2022-03-21 0001640334-22-000544
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.39M 2019-09-01 2020-02-29 2020 Q2 10-Q 2020-04-13 0001640334-20-000802

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →